Compare FATE & DHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FATE | DHX |
|---|---|---|
| Founded | 2007 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.6M | 109.7M |
| IPO Year | 2013 | 2007 |
| Metric | FATE | DHX |
|---|---|---|
| Price | $1.71 | $3.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $4.10 | ★ $6.25 |
| AVG Volume (30 Days) | ★ 3.0M | 294.5K |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.88 | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | $6,646,000.00 | ★ $127,826,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.52 |
| P/E Ratio | ★ N/A | $90.38 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.91 | $1.44 |
| 52 Week High | $2.47 | $3.99 |
| Indicator | FATE | DHX |
|---|---|---|
| Relative Strength Index (RSI) | 49.44 | 70.49 |
| Support Level | $0.99 | $2.17 |
| Resistance Level | $1.94 | N/A |
| Average True Range (ATR) | 0.25 | 0.29 |
| MACD | -0.03 | 0.11 |
| Stochastic Oscillator | 39.76 | 94.55 |
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.